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Catechols undergo two main metabolic pathways, oxidation and conjugation. Oxidation of catechols to electrophilic and redox active semiquinones and o-quinones generates quinoid and reactive oxygen species which cause damage by covalent binding to and oxidation of DNA and other cellular macromolecules. The formation of catechol o-quinones is proposed to imply a unifying mechanism in the development of cancer by catechols, catechol PAH and catechol estrogens (Bolton, 2002 , Penning et al., 1999 , and also in the initiation of Parkinson's disease and other neurodegenerative disorders by dopamine (Cavalieri et al., 2002) .
Characterization of catechol metabolism by sulfation, methylation, and glucuronidation has been evaluated with a set of 53 compounds to clarify common structural features that govern their conjugation pathways. Investigation of the UDP-glucuronosyltransferase isoforms (UGT, EC 2.4. 1.17) that catalyze the glucuronidation of catechols has been performed using five human (h) and two rat (r) cloned and expressed isoenzymes. Thirty-eight catechols were glucuronidated at least by one of the forms hUGT1A1, hUGT1A6, hUGT1A9, hUGT2B7, hUGT2B15, rUGT1A6 and/or rUGT2B1. When these catechols were classified as substrates of recombinant COMT and sulfotransferase (SULT) isoenzymes, 45 were methylated and 48 sulfated, respectively (Antonio et al., 2002 , Lautala et al., 2001 , Taskinen et al., 2003 .
The aim of this study was to investigate the inductive effect of 5 model catechols on the glucuronidation of catechols themselves and noncatecholic UGT probe substrates (1-naphthol, 1-hydroxypyrene) in rats. The well-known inducer, PCB was used as a positive control. Hepatotoxicity of treatment doses was estimated by blood plasma transaminase tests (ALT and AST). Since UGT1A9 and 1A6 isoforms have been previously shown by us to be greatly involved in catechol glucuronidation (Antonio et al. 2002 , Lautala et al., 2000 , the catechol drug entacapone and the DMD #992R with phosphate buffered saline, removed, weighed, cooled in ice, and stored frozen (-70°C) . The experiments were approved by the local Ethical Committee for Animal Studies (the guidelines of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes were followed).
Preparation of microsomes from rat liver
The thawed livers were homogenized in two volumes (w/v) of cold 0.250 M sucrose -1 mM Tris-HCl (pH 7.4) buffer with a Potter-Elvehjem glass homogenizer (Thomas tubes with Teflon pestle). Enzyme fractions were prepared at 5°C by differential ultracentrifugation. The supernatant of the first centrifugation (10,000 x g, 15 min) was run at 106,000 x g for 60 min to obtain as a pellet the microsomal fraction. The pellet was homogenized in 10 ml of buffer, and centrifuged again at 106,000
x g for 60 min. The microsomes were resuspended in the buffer to give a protein content of 10-20 mg/ml, divided in small aliquots and stored frozen in Eppendorf tubes (-70°C) until use. The protein concentrations were determined (Lowry et al., 1951) using commercial protein standards (Preciset DMD #992R 8 before mixed and centrifuged (13,000 rpm, 5 min). The resulting supernatants were injected into a Shimadzu HPLC/CLASS VP 5.021 chromatography system (Shimadzu, Kyoto, Japan) equipped with a Nova-Pak C18 column (4 µm, 150 x 3.9 mm; Waters Co., Milford, MA), SPD-10AV UV-VIS detector (at 305 nm) and an SIL-10A auto injector. Acetonitrile -0.5% acetic acid in Millipore H 2 O (25:75, v/v) was used as the mobile phase for isocratic runs at a flow rate 1 ml/min. Entacapone 3-O-β-D-glucuronide was used for product identification (RT=3.1 min, see Fig. 2 ) and quantitation by peak area calculation. Calibration was based on a 7-point (0 -4 µM) concentration curves (r ≤ 0.99). The enzyme reaction was linear with incubation time (≤ 60 min) and protein concentration (25-150 µg/250 µl).
1-OHP glucuronidation assay.
The reaction mixture contained 25 µl of rat liver microsomes (0.3-3 µg protein) in 1% bovine serum albumin; 120 µl of 50 mM K/Na-phosphate buffer -0.15 M KCl (pH 7.4) with 10 mM MgCl 2 ; 100 µl of 50 mM K/Na-phosphate buffer -0.15 M KCl (pH 7.4) with 11 mM UDPGA (samples) or without UDPGA (controls). The reaction was started (after a 5-7 min preincubation at 37°C) with 5 µl of 1-OHP in dimethylsulfoxide, incubated for 10 min, stopped with 50 µl of cold 15% ZnSO 4 solution, cooled for 15 min in ice bath (protein precipitation) before addition of 500 µl of acetonitrile. The tubes were mixed by Vortex (10 s), sonicated (2 min), and centrifuged (13,000 x g, 10 min, at 20°C). The supernatants were analyzed as described previously (Luukkanen et al., 2001 ) in a Shimadzu HPLC/CLASS VP 5.021 chromatography system (Shimadzu, Kyoto, Japan) using an RF-10Axl fluorescence detector (λ ex 242 nm, λ em 382) and 60% acetonitrile in a 0.5% aqueous acetic acid for isocratic reverse-phase C18 runs. 1-Pyrenyl β-D-glucuronide was used for product identification (RT = 2.5 min) and quantitation by 6-point (0-56 nM) linear calibration curves (r ≥ 0.99) and peak area calculation. The enzyme reaction was linear with incubation time (≤ 30 min) and protein concentration (0.3-4 µg/250 µl).
1-Naphthol glucuronidation. This activity was determined using 70-100 µg of rat liver microsomal protein per a 250-µl reaction mixture and a 500-µM 1-naphthol substrate concentration, but otherwise This article has not been copyedited and formatted. The final version may differ from this version. the reaction conditions were identical with the 1-OHP UGT incubation assay described above. The supernatants were diluted (1:31) in 30% acetonitrile-0.5% aqueous acetic acid (eluent) for isocratic analysis (5-µl injection, flow rate 0.9 ml/min) with a reverse-phase C 18 guard cartridge (Spherisorb S5 ODS2, 30 x 4.6 mm) and an analytical column S3 ODS2, 150 x 4.6 mm (Waters Spherisorb, Wexford, Ireland) using an RF-10Axl fluorescence detector (λ ex 290 nm, λ em 332) and a SIL-10ADvp auto injector in a Shimadzu HPLC/CLASS VP 6.12 SP2 chromatography system. 1-Naphthol β-Dglucuronide was used for product identification (RT = 4.1 min) and quantitation by 6-point linear calibration curves (0, 0.1, 0.3, 0.6, 0.8, 1.0, 1.5 µM; r = 1.00) and peak area calculation. The enzyme reaction was linear with incubation time (≤ 20 min; protein 150µg/250µl) and protein concentration (37-300µg/250 µl; 10-min incubation).
Glucuronidation of catechol, 4-methylcatechol, 4-nitrocatechol, DHN, entacapone and tolcapone. A
thin layer chromatographic method was used for this purpose (Antonio et al., 2002) 
Results

Effects of catechol and PCB pretreatment in the rats
The effects of administration of catechols were investigated after a 3-day treatment of rats with relatively high oral doses of 4-methylcatechol, 4-nitrocatechol, DHN, entacapone or tolcapone (Table   1) . High dose of 4-nitrocatechol caused diarrhea in rats. DHN had a clear narcotic and paraplegic effect in one of 5 rats, but only after the first administration. Plasma ALT / AST levels were analyzed for possible treatment related hepatotoxicity. A slight elevation of AST (33%) was observed in DHNexposed rats. Liver weight was not increased in the catechol-treated groups, whereas the PCB-exposed rats exhibited a hepatomegaly (increases in liver weights 55%) and increases in plasma AST levels (37%) ( Table 1) .
Glucuronidation of catechols, 1-naphthol, and 1-OHP in liver microsomes of rats pretreated with model catechols or PCB Induction of catechol glucuronidation upon exposure to five different model catechols ( Fig. 1 ) was assessed by using the inducing agents themselves as probe substrates in vitro. The specific glucuronidation activity toward these catechols and the catechol itself was determined at a 0.5-mM aglycone and a 2.5 mM glucuronic acid substrate levels. The results are shown in Fig The ability of catechols to induce glucuronidation metabolism in rat liver was determined by the substrates entacapone, 1-naphthol, and 1-OHP as shown in Table 2 . Aroclor 1254 treatment enhanced the glucuronidation of 1-naphthol, entacapone, and 1-OHP by 5-, 8-, and 16-fold, respectively, whereas the catechols exhibited only an weak or no effect at all. Some slight increases were observed in rats treated with 4-methylcatechol (low dose), DHN, entacapone or tolcapone in the activities towards 1-naphthol (24-30%), entacapone (25-50%), and 1-OHP (11-39%). For the UGT enzyme induction studies shown in Table 2 , the substrate concentration selected for screening of UGT by 1-OHP and entacapone are based on the enzyme kinetics shown in Fig. 4 and 5. The 1-OHP UGT assay is extremely sensitive, allowing activity measurement at low substrate concentrations. When the glucuronidation activity was determined at a concentration as low as 1 µM, the turnover was 16 times faster in PCB microsomes than in control microsomes. At the higher probe concentrations, 15, 100, and 150 µM the glucuronidation rates were increased 10-fold, 4-fold, and 5-fold, respectively ( Table   2 ).
Kinetics of entacapone and 1-OHP glucuronidation in rat liver microsomes
The initial velocities of the glucuronidation of 1-OHP (Fig. 4) or entacapone ( was catalyzed in catechol compound treated rats predominantly by one isoenzyme but in PCB microsomes by several forms. Up to three components could be resolved for 1-OHP glucuronidation data: K m1 , K m2 , K m3 = 0.8, 9.7, 63 µM, and V max1 , V max2 , V max3 = 11, 24, and 55 nmol/min/mg, respectively. The corresponding V max /K m values were 13.8, 2.5, and 0.9 ml/min/mg, respectively ( 
Discussion
UGTs are a super family of membrane-bound enzymes, which catalyze the transfer of glucuronic acid from the donor substrate, UDPGA, on hydroxyl groups of a variety of substances (Burchell et al., 1995 , Burchell et al., 1998 , Clarke and Burchell, 1994 , Mackenzie et al., 1997 , Tukey and Strassburg, 2000 . The reaction leads to the formation of hydrophilic glucuronides, which can be excreted into bile and urine (Antonio et al., 2002 , Jorga et al., 1999 , Keski-Hynnilä et al., 2002 , Wikberg et al., 1993 . In this work, we determined, using dedicated TLC or HPLC methods, the glucuronidation activity of different catecholic substrates, and of the antiparkinsonian drugs tolcapone and entacapone.
The average rates at which these catechols were glucuronidated in liver microsomes of control rats differed up to 183-fold, entacapone being glucuronidated at the lowest rate, while 4-nitrocatechol was actively glucuronidated. These data revealed the importance of the structure of the chemical group on the catechol ring on the glucuronidation reaction.
Compared to the effects by the highly potent inducer, PCB, the glucuronidation rate of catechols showed only marginal alterations in response to the present catechol treatments. Under the experimental conditions used here, catechols appeared to present no inducing properties. The data on the inductive effect of PCB on catechol glucuronidation could be favorably compared to those of Antonio et al. (2002) , who determined the induction potency of 3-methylcholanthrene, phenobarbital or, the peroxisome proliferator, clofibrate, on the glucuronidation of 41 catechols. The results indicated that only 3-methylcholanthrene could enhance catechol glucuronidation, thus indicating that UGT isoforms (UGT1 family) could be involved in catechol glucuronidation. The PAH-type of induction, e.g., by 3-methylcholanthrene, ß-naphthoflavone, TCDD, PAH, or PCB is regulated by aryl hydrocarbon receptor, which functions as ligand-activated transcription factor in over expression of the forms rUGT1A6, rUGT1A7, hUGT1A6 and hUGT1A9 (Bock et al., 1998 (Bock et al., , 1999 . Other typical co-effects achieved by using Aroclor 1254 as the inducing PCB agent (Safe, 1994 ) are a phenobarbital-type of induction and hepatomegaly, which accounted for a 55% increase in the liver weights (Table 1) .
This article has not been copyedited and formatted. The final version may differ from this version. PCB-induction enhanced the glucuronidation of all six catechols significantly as shown in Fig. 3 and that of 1-naphthol and 1-OHP as well (Table 2) . Although the activity increased relatively more with entacapone (8-15 times) than with 4-nitrocatechol (1.3-fold), 4-nitrocatechol was still conjugated 14 times faster than entacapone. In control microsomes, entacapone was conjugated 4 times slower than tolcapone, but upon UGT induction by Aroclor 1254, the rates became similar. Creosote is also a PAH-type inducer that enhances entacapone glucuronidation more than that of tolcapone . The finding that entacapone glucuronidation was enhanced relatively more than the tolcapone glucuronidation suggests differential kinetics of PCB-inducible UGTs toward these COMTinhibitor drugs. Moreover, we have found that entacapone glucuronidation was enhanced in rat liver over 6-fold upon exposure to ß-naphthoflavone, benzo(a)pyrene, or 3-methylcholanthrene, while exposure to α-naphthoflavone, or chrysene had an intermediary effect (a 2-fold increase). Finally the PAHs, naphthalene, phenanthrene, and pyrene caused no effect (unpublished results).
Entacapone was glucuronidated in rat liver microsomes by an as yet uncharacterized rUGT. When we compare the apparent K m and V max values shown in Fig. 5 with the kinetic parameters reported in human liver microsomes (K m = 47 µM, V max = 6.8 nmol/min/mg) by Lautala et al. (2000) , it appears that entacapone is conjugated by rUGTs less efficiently than by forms expressed in human liver (UGT1A9). Moreover, a manifold induction of entacapone glucuronidation was consistently detected in PCB-treated animals ( Table 2 , Fig. 3 ). Enzyme kinetic data (Fig. 5) showed that the apparent K m value for entacapone-metabolizing activity was lower in PCB rats (130 µM) than that in control rats (237 µM).
1-Naphthol was used as a phenol UGT marker substrate for rat UGT1A6. As shown by Jackson et al.
(1988), 1-naphthol is one of the most rapidly glucuronidated substrates by this enzyme which exhibits a restricted specificity towards planar phenols. Also, with this substrate, a significant UGT induction was detected in PCB-treated rats (Table 2 ). This finding is in agreement with that reported for Aroclor 1254 by Oesch et al. (1992) . We have also found that 1-naphthol glucuronidation is enhanced in rat liver 3-4-fold upon exposure to PAH-type inducers such as ß-naphthoflavone, benzo(a)pyrene, or 3-This article has not been copyedited and formatted. The final version may differ from this version. methylcholanthrene, while exposure to PAHs like naphthalene, phenanthrene, or pyrene has no effect (unpublished results).
1-OHP is a sensitive probe for detecting UGT induction by chemical inducers of the PAH-type. We have shown that 1-OHP (at a 3-µM concentration) is glucuronidated 5 and 8 times faster in liver microsomes of rats treated by 3-methylcholanthrene and PCB, respectively, than by control microsomes (Luukkanen et al., 1997) . 1-OHP is also a UGT selective substrate as inferred from enzyme kinetic data obtained in rats treated with different model inducers: control < pyrazole < acetone < phenobarbital < 4,4'-methylenebis-(2-chloroaniline) (MOCA) < 3-methylcholanthrene < creosote < PCB (V max /K m , 0.11, 0.19, 0.22, 0.43, 0.46, 2.05, 2.41, and 3.01 ml/min/mg, respectively).
Application of 1-OHP as a selective marker of the PAH-type inducible phenol UGT forms (low-K m , high V max /K m ) requires testing at a low substrate concentration. Despite the high sensitivity of the 1-OHP UGT assay, only slight inductive effects could be observed in catechol-pretreated rats, whereas in the PCB-treated rats, the glucuronidation rate rose drastically ( Table 2 ).
The glucuronidation kinetic constants estimated from the Michaelis-Menten and Eadie-Hofstee plots gave very similar values for K m and V max . An exception was the 1-OHP kinetic data analyzed in PCBinduced microsomes (Fig. 4 and 5) . The enzyme kinetic data of both 1-OHP and entacapone glucuronidation agree with the above findings (Table 2 and Fig. 3 ) which indicate that catechols are poor inducers of hepatic UGT activities in the rat. In the light of the kinetic data, we can conclude that PCB-induced several UGT activities and, in particular, high affinity enzyme forms, probably efficient catalysts of phenolic compounds, including catecholic compounds.
Entacapone (hUGT1A9), 1-naphthol (hUGT1A6) and 1-OHP (hUGT1A6/1A9) are preferentially conjugated by these two human isozymes, which are, in most cases, recognized as the major catalysts of catechol glucuronidation. Large differences are, however, observed in the glucuronidation rates among individual catechols as found here and in previous studies (Antonio et al., 2002 , Taskinen et al., 2003 . For this reason, it is important to study in each case also the glucuronidation by the catechol 
